Alaunos Therapeutics (TCRT)

• Market cap: $6.65M
• 1 day: -10.78%
• 5 days: -3.25%
• 1 month: 9.96%
• 3 months: 30.7%
• 6 months: 10.37%
• Year to date: 51.27%
• 1 year: 15.5%
• 5 years: -99.3%
• 10 years: -99.84%
• Sector: Healthcare
• Industry: Biotechnology

About: Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

Employees: 1